The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, J.
Right arrow Articles by Kneitz, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, J.
Right arrow Articles by Kneitz, B.
The Journal of Immunology, 2006, 176: 2389-2396.
Copyright © 2006 by The American Association of Immunologists

B Cell-Specific Deficiency for Smad2 In Vivo Leads to Defects in TGF-beta-Directed IgA Switching and Changes in B Cell Fate1

Jörg Klein*, Wenjun Ju§, Jörg Heyer§, Britta Wittek2,{dagger}, Torsten Haneke{ddagger}, Petra Knaus3,{dagger}, Raju Kucherlapati, Erwin P. Böttinger§, Lars Nitschke4,5,* and Burkhard Kneitz4,5,{ddagger}

* Institute for Virology and Immunobiology, {dagger} Department of Physiological Chemistry II, Biocenter, and {ddagger} Department of Physiological Chemistry I, Biocenter, University of Würzburg, Würzburg, Germany; § Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029; and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115

Smad2 is a member of the intracellular mediators that transduce signals from TGF-beta receptors and activin receptors. Targeted inactivation of Smad2 in mice leads to early lethality before gastrulation. It was shown previously that TGF-betaRII deficiency in vivo leads to defects in B cell homeostasis, Ag responsiveness, and IgA class switch recombination of B cells. To investigate the importance of Smad2-mediated signaling in B lymphocytes, we generated a B cell-specific inactivation of Smad2 in mice (bSmad2–/–). bSmad2–/– mice had normal B cell numbers in the spleen but showed a reduced population of marginal zone B cells. In contrast, B cells in Peyer’s patches and peritoneal B-1a cells of bSmad2–/– mice were increased in numbers. bSmad2–/– mice showed a reduced number of surface-IgA+ B cells and of IgA-secreting cells in Peyer’s patches, decreased levels of IgA in serum, and, after immunization with a T cell-dependent Ag, a reduced IgA response. Class switch recombination to IgA was impaired in Smad2-deficient B cells, when stimulated in vitro with LPS in the presence of TGF-beta. The growth-inhibitory effects of TGF-beta in LPS-stimulated B cells were not affected in Smad2-deficient B cells. In summary, our data indicate a crucial role of Smad2 in mediating signals for the TGF-beta-directed class switch to IgA and the induction of IgA responses in vivo. Other B cell functions like growth-inhibitory signaling, which are known to be regulated by signals via the TGF-betaR, are not affected in Smad2-deficient B cells.


Related articles in The JI:

IN THIS ISSUE

The JI 2006 176: 2051-2052. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.